Uses of a familial adenomatous polyposis registry

K U A Dalpatadu1, N Anwar, S R E Wijesuriya

  • 1Department of Surgery, University of Kelaniya, Sri Lanka. udalpatadu@gmail.com

Insights

Establishing a familial adenomatous polyposis (FAP) register enables early diagnosis and prophylactic treatment, improving patient prognosis. This coordinated approach optimizes clinical management for FAP patients and at-risk relatives.

Area of Science:

  • Gastroenterology
  • Clinical Genetics
  • Oncology

Background:

  • Familial adenomatous polyposis (FAP) is an inherited condition predisposing individuals to colorectal cancer.
  • Early diagnosis and proactive management are crucial for improving FAP patient outcomes.
  • A coordinated registry system can enhance the identification and care of at-risk individuals.

Purpose of the Study:

  • To establish and analyze a prospective database for a Familial Adenomatous Polyposis (FAP) registry.
  • To improve the prognosis of FAP patients through early detection and prophylactic treatment.
  • To coordinate and optimize the clinical management of FAP patients and their relatives.

Main Methods:

  • Establishment of a prospective FAP registry database.
  • Ascertainment of probands, pedigree construction, and genetic counseling for at-risk relatives.
  • Prophylactic screening, treatment, and follow-up of individuals identified with FAP or at risk.

Main Results:

  • The registry identified 27 probands, with 206 relatives at risk, and screened 24 family members.
  • Thirty-five individuals were diagnosed with FAP, including 8 detected through screening and 27 symptomatic cases.
  • Colorectal cancer was detected in 63% of symptomatic and 13% of screen-detected FAP patients. Extraintestinal manifestations were also noted.

Conclusions:

  • A polyposis register facilitates early detection of Familial Adenomatous Polyposis (FAP), potentially improving patient prognosis.
  • The registry aids in coordinating and streamlining the clinical management of FAP patients and their at-risk family members.
  • Systematic registration and screening are vital for optimizing care and outcomes in hereditary polyposis syndromes.
Abstract

Related Concept Videos